Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides
Clinical trial NCT00074087 · COMPLETED
Trial details
- NCT number
- NCT00074087
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-10-01
- Primary completion
- 2009-07-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.